Don’t Drop the B: Risk of Hepatitis B Virus Infection and Reactivation in the Era of Tenofovir-Sparing Regimens for Treatment and Prevention of HIV

By afschroeder • May 28, 2026

Lee TH, Bhattacharya D, Kim HN. Don't Drop the B: Risk of Hepatitis B Virus Infection and Reactivation in the Era of Tenofovir-Sparing Regimens for Treatment and Prevention of HIV. Clin Infect Dis. 2026 May 27:ciag322. doi: 10.1093/cid/ciag322. Epub ahead of print. PMID: 42200461.

Tags: HBV, HIV, Infectious Diseases, Pre-exposure prophylaxis, Publications, Tenofovir, Veterans Administration

Clinical and genomic characteristics of hypervirulent Klebsiella pneumoniae isolated from throat culture suggesting an emerging causative agent of pharyngitis

Whitehill GD, Gonzalez-Ferrer S, Tsan AT, Yang S. Clinical and genomic characteristics of hypervirulent Klebsiella pneumoniae isolated from throat culture suggesting an emerging causative agent[...]

Th2 skewing in patients with disseminated coccidioidomycosis

Thauland TJ, Nagarajan SS, Stephens AV, Jensen SL, Srivastava A, Moreno Lastre MA, Ahn TS, Bun C, Trump MT, Johnson RH, Thompson GR 3rd, Garcia-Lloret[...]

Emerging Dolutegravir Resistance Among Children on Antiretroviral Therapy With Virological Failure in Malawi: Results From a 2023 National Cross-Sectional Survey

Bello G, Kabaghe AN, Pals S, Kalata NL, Bighignoli B, van Oosterhout JJ, Mkungudza J, Agyemang E, Zheng DP, Panja L, Matola WB, Chitenje M,[...]